BIOC-11 is under development for the treatment of bronchiectasis caused by Pseudomonas aeruginosa and cystic fibrosis. This candidate is formulated as an isotonic, buffered aqueous solution for oral ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

pulmonary fibrosis — have been shown to be potential factors in the etiology of bronchiectasis. Of these, congenital cystic disease and bronchostenosis are comparatively uncommon. Bronchial ...

In 2023, there were approximately 77,445 diagnosed prevalent cases of cystic fibrosis bronchiectasis across the 7MM. Of these, the US accounted for about 53.7%, EU4 and the UK made up around 46.3% ...

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.

In 2023, there were approximately 77,445 diagnosed prevalent cases of cystic fibrosis bronchiectasis across the 7MM. Of these, the US accounted for about 53.7%, EU4 and the UK made up around 46.3%, ...

(RTTNews) - 2024 has been a banner year for Verona Pharma (VRNA), with its share price surging more than threefold in just 7.5 months. The ...

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.

Considering taking supplements to treat bronchiectasis? Below is a list of common natural remedies used to treat or reduce the symptoms of bronchiectasis. Follow the links to read common uses ...